Abstract
The p53 gene is a tumour suppressor gene frequently mutated in human cancers. Its product is a transcription factor that regulates the expression of various genes involved in cell cycle arrest and in apoptosis in response to different cellular stresses. The recent discovery of two p53 gene homologs, p73 and p63, has uncovered a family of transcription factors and widened the scenario of cell cycle control and apoptosis. p73 and p63 genes encode proteins showing significant structural and functional similarity to p53, although important differences are emerging. p73 and p63 have an additional domain in their carboxyl-terminal region with marked similarity to the structure of SAM (sterile alpha motif) domains, typical of proteins involved in development. Indeed, differently from p53, p63 and p73 seem to be involved in development and differentiation. Both p73 and p63, at least when overproduced, can activate some of the p53-responsive promoters and trigger growth arrest and apoptosis, although their an swers in response to DNA damage differ from those of p53. The challenge is now to understand similarities and differences between family members especially in terms of their functions, regulation and interactions. This review summarizes the present knowledge on the structural, functional and evolutionary features of the p53 gene family and focuses on the differences among the three members of the family.
Current Genomics
Title: p53 Gene Family: Structural, Functional and Evolutionary Features
Volume: 4 Issue: 1
Author(s): D'Erchia A. M., Tullo A., Pesole G., Saccone C. and Sbisa E.
Affiliation:
Abstract: The p53 gene is a tumour suppressor gene frequently mutated in human cancers. Its product is a transcription factor that regulates the expression of various genes involved in cell cycle arrest and in apoptosis in response to different cellular stresses. The recent discovery of two p53 gene homologs, p73 and p63, has uncovered a family of transcription factors and widened the scenario of cell cycle control and apoptosis. p73 and p63 genes encode proteins showing significant structural and functional similarity to p53, although important differences are emerging. p73 and p63 have an additional domain in their carboxyl-terminal region with marked similarity to the structure of SAM (sterile alpha motif) domains, typical of proteins involved in development. Indeed, differently from p53, p63 and p73 seem to be involved in development and differentiation. Both p73 and p63, at least when overproduced, can activate some of the p53-responsive promoters and trigger growth arrest and apoptosis, although their an swers in response to DNA damage differ from those of p53. The challenge is now to understand similarities and differences between family members especially in terms of their functions, regulation and interactions. This review summarizes the present knowledge on the structural, functional and evolutionary features of the p53 gene family and focuses on the differences among the three members of the family.
Export Options
About this article
Cite this article as:
M. A. D'Erchia, A. Tullo, G. Pesole, C. Saccone and E. Sbisa, p53 Gene Family: Structural, Functional and Evolutionary Features, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350173
DOI https://dx.doi.org/10.2174/1389202033350173 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies
Current Pharmaceutical Design Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry Banking Strategies for Improving the Hematopoietic Stem Cell Content of Umbilical Cord Blood Units for Transplantation
Current Stem Cell Research & Therapy New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms
Current Medicinal Chemistry ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells
Anti-Cancer Agents in Medicinal Chemistry Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: A Hypothesis
Current Stem Cell Research & Therapy Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Targeting Prostate Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Low Content of Protein S29 in Ribosomes of Human Lung Cancer Cell Line A549: Detected by Twodimensional Electrophoresis
Protein & Peptide Letters Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review
Current Drug Metabolism Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Detecting Growing Mammary Tumors with Monoclonal Antibodies Against Vascular Endothelial Growth Factor Receptor – 3
Current Radiopharmaceuticals Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Current Pharmaceutical Design Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
Current Cancer Drug Targets Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy
Current Pharmaceutical Design Thioredoxin System Modulation by Plant and Fungal Secondary Metabolites
Current Medicinal Chemistry Synergistic Activities of a Silver(I) Glutamic Acid Complex and Reactive Oxygen Species (ROS): A Novel Antimicrobial and Chemotherapeutic Agent
Current Medicinal Chemistry